Pharmaceutical Cleanroom Industry Articles

Viant Completes Major Expansion of Costa Rica Manufacturing Facility

Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. The expansion will benefit customers by enhancing Viant’s ability to provide speed to market for high-quality, complex medical devices.

Matica Biotechnology, Inc. Announces Groundbreaking for New GMP Facility

Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, ceremonially broke ground today on its new 25,000 ft2 facility which will house its GMP virus production suites, development laboratories and company offices. The new building will be located in Providence Park at 2501 Earl Rudder Freeway in College Station.

NuTec Employs Epson Cleanroom SCARA Robots to Automate Medical Syringe Manufacturing, Including a COVID-19 Medical Application

Cleanroom SCARA Robots to Automate Medical Syringe Manufacturing, Including a COVID-19 Medical Application
NuTec’s Syringe Coating Machine Includes Four Epson G6 Cleanroom SCARA Robots to Precisely, Efficiently, and Cost-Effectively Automate Syringe Manufacturing

Nanotech Powered Mass Testing Now the Key to Unlocking COVID-19 Lockdowns

The World Nano Foundation and pandemic experts say regular use of inexpensive lateral flow rapid antigen mass testing kits is the way to beat COVID-19, its variants and future viruses.

Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

Berry Global Unveils the United States’ First Comprehensive, Commercial-Scale Clean Room for Nine-Layer Blown Film Manufacturing

Berry Global Unveils the United States’ First Comprehensive, Commercial-Scale Clean Room for Nine-Layer Blown Film Manufacturing

The ISO 7 class clean room can produce nine-layer blown film. The new installation fully encloses commercial-scale production of Berry’s proprietary nine-layer blown film from extrusion to packaging, a first in the United States. The addition further enhances Berry’s ability to supply more sensitive applications such as sterile intravenous solution bags, pharmaceutical packaging, medical equipment manufacturing, and microchip packaging.

Cystic Fibrosis Therapy Improved by Lipid-Based Nanoparticles

Cystic Fibrosis Therapy Improved by Lipid-Based Nanoparticles

Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients. Cystic fibrosis is a progressive genetic disorder that results in persistent lung infection and afflicts 30,000 people in the U.S., with about 1,000 new cases diagnosed every year.

read more
HPAPI Facility launches for production of the highest class of HPAPI

HPAPI Facility launches for production of the highest class of HPAPI

Minakem’s HPAPI production will be carried out with an Occupational Exposure Limit (OEL) below 0,1μg/m3/8h. This emphasis on Environment, Health and Safety (EHS) reflects Minakem’s more than 20 years’ experience in continuously monitoring and controlling hazardous working environments, marking its leadership in this area.

read more
New State-of-the-Art Plasma Manufacturing Facility

New State-of-the-Art Plasma Manufacturing Facility

Shire plc, the global biotechnology leader in rare diseases, announced today that the United States Food and Drug Administration (FDA) has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency (PI).

read more
Novacap Expands Pharmaceutical Offering with Acquisition of PCI Synthesis

Novacap Expands Pharmaceutical Offering with Acquisition of PCI Synthesis

Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO), further reinforcing Novacap’s capabilities and offering for the pharmaceutical industry.

read more